feed,title,long_url,short_url
Benzinga,Merck's Keytruda Tops Placebo On Overall Survival Endpoint In Liver Cancer Patients,https://benzinga.com/general/biotech/21/09/23112625/mercks-keytruda-tops-placebo-on-overall-survival-endpoint-in-liver-cancer-patients,https://j.mp/3EZ78Fq
Benzinga,Analysts See Up To 71% Upside In DoubleDown Interactive - Read Why,https://benzinga.com/analyst-ratings/analyst-color/21/09/23112748/analysts-see-up-to-71-upside-in-doubledown-interactive-read-why,https://j.mp/3m2T8BZ
